How does it compare to statins? Should you take it? And how much does it cost? By Nina Agrawal and Gina Kolata Patients who need to lower their cholesterol will soon have a powerful new option. On ...

The US Food and Drug Administration has approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for reducing LDL cholesterol alongside diet and exercise in adult patients with ...

The U.S. Food and Drug Administration has approved a new cholesterol-busting drug that appears to reduce harmful cholesterol far below levels than can be achieved using statins. Statins have long been ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved LIPFENDRA ® (enlicitide ...

Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up to 62% with a single infusion. Not only was the experimental treatment successful, but ...

People generally have an idea of foods they consider cholesterol-heavy: ultra-processed, extra-flavorful options and ones that take a lot of “sizzle” to create. But many foods that raise cholesterol ...

Spring is finally on its way to Cambridge, but before the magnolias bloom, we must endure the inevitable floods of Spring rain. If you find yourself stuck indoors this week, there’s no better ...

There are two main types of cholesterol in the body — HDL or “good” cholesterol, and LDL or “bad” cholesterol. Having higher levels of LDL cholesterol can potentially lead to atherosclerosis and ...

For patients with atherosclerotic cardiovascular disease (ASCVD), targeting a low-density lipoprotein (LDL) cholesterol level of <55 mg/dL results in a lower risk for cardiovascular events, according ...

Despite guideline recommendations, evidence from randomized trials evaluating the appropriate low-density lipoprotein (LDL) cholesterol target for secondary prevention in patients with atherosclerotic ...